HSPA9
Basic information
Region (hg38): 5:138553756-138575675
Previous symbols: [ "HSPA9B" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant sideroblastic anemia (Strong), mode of inheritance: AD
- autosomal dominant sideroblastic anemia (Moderate), mode of inheritance: AR
- even-plus syndrome (Limited), mode of inheritance: AR
- autosomal recessive sideroblastic anemia (Supportive), mode of inheritance: AR
- even-plus syndrome (Supportive), mode of inheritance: AR
- even-plus syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Anemia, sideroblastic 4; Even-Plus syndrome | AD | Cardiovascular; Hematologic; Renal | Individuals with anemia have been described with anemia requiring RBC transfusions in some individuals, and awareness may allow for surveillance and prompt management; EVEN-plus syndrome may involve congenital anomalies (eg, cardiac anomalies) that require early identification and interventions for management | Cardiovascular; Craniofacial; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal | 3653362; 26491070; 26598328 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSPA9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 16 | ||||
missense | 22 | 25 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 3 | |||||
Total | 1 | 2 | 22 | 16 | 5 |
Variants in HSPA9
This is a list of pathogenic ClinVar variants found in the HSPA9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-138556060-C-G | Inborn genetic diseases | Uncertain significance (Aug 08, 2022) | ||
5-138556101-C-T | Inborn genetic diseases | Uncertain significance (Apr 07, 2022) | ||
5-138556104-T-C | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
5-138556470-G-A | Likely benign (Oct 01, 2022) | |||
5-138556481-G-A | Even-plus syndrome | Conflicting classifications of pathogenicity (Aug 25, 2023) | ||
5-138556500-G-A | HSPA9-related disorder | Likely benign (Mar 12, 2019) | ||
5-138556533-G-A | Benign (Dec 31, 2019) | |||
5-138556549-A-G | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
5-138556782-C-A | Inborn genetic diseases | Uncertain significance (Oct 29, 2021) | ||
5-138557400-A-C | Likely pathogenic (Oct 09, 2020) | |||
5-138557409-C-T | Inborn genetic diseases | Uncertain significance (Apr 25, 2022) | ||
5-138557411-C-G | Likely benign (Feb 08, 2018) | |||
5-138557993-T-G | HSPA9-related disorder | Likely benign (May 24, 2019) | ||
5-138557995-A-C | Likely benign (Dec 31, 2019) | |||
5-138558545-TA-T | HSPA9-related disorder | Benign (Dec 31, 2019) | ||
5-138558559-A-G | HSPA9-related disorder | Likely benign (Apr 25, 2018) | ||
5-138558563-T-C | Inborn genetic diseases | Uncertain significance (May 20, 2024) | ||
5-138558642-C-T | HSPA9-related disorder | Uncertain significance (May 01, 2023) | ||
5-138559873-C-T | Likely benign (Nov 15, 2018) | |||
5-138559895-CTATTAA-C | Autosomal dominant sideroblastic anemia | Uncertain significance (Jul 01, 2024) | ||
5-138559927-A-G | Likely benign (Nov 01, 2023) | |||
5-138559944-A-T | Inborn genetic diseases | Uncertain significance (Oct 04, 2022) | ||
5-138560024-A-G | Inborn genetic diseases | Uncertain significance (May 05, 2023) | ||
5-138561584-G-C | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
5-138561607-A-G | Likely benign (Aug 01, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSPA9 | protein_coding | protein_coding | ENST00000297185 | 17 | 20563 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.969 | 0.0315 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.04 | 312 | 368 | 0.848 | 0.0000200 | 4447 |
Missense in Polyphen | 87 | 148.71 | 0.58503 | 2008 | ||
Synonymous | -0.267 | 133 | 129 | 1.03 | 0.00000677 | 1346 |
Loss of Function | 4.74 | 6 | 37.2 | 0.161 | 0.00000225 | 420 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000213 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000282 | 0.000281 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Chaperone protein which plays an important role in mitochondrial iron-sulfur cluster (ISC) biogenesis. Interacts with and stabilizes ISC cluster assembly proteins FXN, NFU1, NFS1 and ISCU (PubMed:26702583). Regulates erythropoiesis via stabilization of ISC assembly (PubMed:21123823, PubMed:26702583). May play a role in the control of cell proliferation and cellular aging (By similarity). {ECO:0000250|UniProtKB:P38647, ECO:0000269|PubMed:21123823, ECO:0000269|PubMed:26702583}.;
- Disease
- DISEASE: Anemia, sideroblastic, 4 (SIDBA4) [MIM:182170]: A form of sideroblastic anemia, a bone marrow disorder defined by the presence of pathologic iron deposits in erythroblast mitochondria. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus. SIDBA4 has been reported to be inherited as an autosomal recessive disease, with a pseudodominant pattern of inheritance in some families. {ECO:0000269|PubMed:26491070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Even-plus syndrome (EVPLS) [MIM:616854]: An autosomal recessive syndrome characterized by epiphyseal and vertebral dysplasia, prenatal-onset short stature, a distinct craniofacial phenotype with microtia, a flat facial profile with flat nose and triangular nares, cardiac malformations, and additional findings such as anal atresia, hypodontia, aplasia cutis, and others. {ECO:0000269|PubMed:26598328}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- RNA degradation - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Parkin-Ubiquitin Proteasomal System pathway;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Regulation of HSF1-mediated heat shock response;Cellular responses to stress;Metabolism of proteins;Cellular responses to external stimuli;Cellular response to heat stress;Mitochondrial protein import
(Consensus)
Recessive Scores
- pRec
- 0.734
Intolerance Scores
- loftool
- 0.423
- rvis_EVS
- -0.85
- rvis_percentile_EVS
- 11.06
Haploinsufficiency Scores
- pHI
- 0.624
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.835
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hspa9
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Zebrafish Information Network
- Gene name
- hspa9
- Affected structure
- blood cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- response to unfolded protein;iron-sulfur cluster assembly;erythrocyte differentiation;cellular response to heat;cellular response to unfolded protein;interleukin-12-mediated signaling pathway;protein refolding;negative regulation of apoptotic process;regulation of erythrocyte differentiation;negative regulation of erythrocyte differentiation;chaperone cofactor-dependent protein refolding
- Cellular component
- nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;focal adhesion;mitochondrial nucleoid;extracellular exosome
- Molecular function
- RNA binding;protein binding;ATP binding;ATPase activity;heat shock protein binding;ubiquitin protein ligase binding;ATPase activity, coupled;protein folding chaperone;unfolded protein binding;misfolded protein binding